Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Zuellig Pharma

Asia Deal Watch: Qpex Partners Its Experimental Antibiotics With Brii In Greater China

Qpex licenses rights to its antibiotic portfolio in China to Brii Biosciences. Moberg and DongKoo partner on commercialization of onychomycosis therapy in Korea.

Deals Asia Pacific

Interview: DKSH Building Healthcare Services In Changing Asian Markets

Market expansion services provider has its headquarters in Switzerland but a long history and most of its business in Southeast Asia, where the global head of its Business Unit Healthcare tells Scrip it continues to build a broad range of services based around knowledge and penetration of local markets.

Asia Pacific Business Strategies

Boryung Expands In Asia Through Zuellig Deal

Boryung Pharm's original antihypertensive drug continues to increase its global presence, this time through the biggest license agreement so far for the product, with Zuellig Pharma, which will enable the South Korean pharma to sell fimasartan in the rapidly growing Southeast Asian markets.

BioPharmaceutical Asia Pacific

Three Years, Seven Acquisitions Later, Cardinal Health Has More Plans In China

U.S. distributor Cardinal Health goes full speed ahead in China. It has bought local players to tap into the regional market, doubled direct-to-patient pharmacies, and provided pharmacy management services to large hospitals among endeavors in the past three and a half years with more to come.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Services
UsernamePublicRestriction

Register